Ian Hoban, Pilatus Comparator Solutions, poses some key questions that should be front...
- The Dawn of Cell Therapies, Blockchain, and M&A: Industry Trends in the CMO Landscape
- Elucidating Opportunities for Cost Reduction of Clinical Trials Through Supply Management Optimization
- Industry Viewpoints: Digitizing Clinical Manufacturing
- The Brexit Clock is Ticking, Are You Ready?
- Expert Insights: Serialization is a Necessary Step to Pharma Industry’s Adoption of Blockchain
Strategic Comparator Sourcing – A Matter of High Priority
Ian Hoban, Pilatus Comparator Solutions, poses some key questions that should be front of mind and considered early on in the design of your clinical trial
The Dawn of Cell Therapies, Blockchain, and M&A: Industry Trends in the CMO Landscape
Peter Shapiro, Editor-In-Chief, PharmSource, a GlobalData Product, assesses key trends currently changing the face of the contract manufacturing industry
Global Standards for Identification: Untapped Opportunities in the Clinical Trial Supply Chain
Jesper Franke, Head of Healthcare, GS1 Denmark, explains how the industry can best improve supply chain processes by adopting industry standards
Elucidating Opportunities for Cost Reduction of Clinical Trials Through Supply Management Optimization
Anthony Zuccarello, Associate Director, IRT and Global Clinical Supply Strategy, Amicus Therapeutics, offers insight on how to create efficiencies within the clinical supply chain
Industry Viewpoints: Digitizing Clinical Manufacturing
Clive E. Badman, OBE, talks to CTA’s Charlie Abrines about the digitization of the clinical supply chain
Early Phase Trials: Streamlining Your Biologics Process to Optimize Supply
Jonas Fransson, Director Drug Product Development, Swedish Orphan Biovitrum AB, shares the steps and activities to get your biological clinical trial material ready
Industry Viewpoints: Investigator-Initiated Studies – A Challenge for Supply with IMPs?
Peter Orosz, Head of Clinical Supply Chain Management & Oncology, Boehringer Ingelheim, addresses the challenges of investigator-initiated clinical trials
Serialization of Prescription Drugs: Readiness from Development into Commercialization
Hector Tamburini, Exec. Director, Regulatory Affairs & CMC, Prometheus Laboratories, examines how the industry needs to comply with regulations concerning serialization